SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 07/25/23
Zai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023GlobeNewsWire • 07/20/23
JAMA Oncology Publishes Data from Zai Lab Study Demonstrating Significant Reduction in Disease Progression or Death with ZEJULA (Niraparib) Maintenance Therapy in Broad Population of Advanced Ovarian Cancer PatientsGlobeNewsWire • 07/19/23
Zai Lab and argenx Report Positive Topline Data from ADHERE Study of VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating PolyneuropathyGlobeNewsWire • 07/17/23
Zai Lab Announces First Patient Treated in Mainland China for the Global Phase 3 FORTITUDE-101 Study of Bemarituzumab in First-Line Gastric CancerGlobeNewsWire • 07/14/23
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 07/13/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLABPRNewsWire • 07/12/23
Zai Lab Announces Acceptance by China's NMPA of the BLA for Efgartigimod Alfa Injection (Subcutaneous Injection) for Patients with Generalized Myasthenia GravisGlobeNewsWire • 07/10/23
ROSEN, A TOP RANKED LAW FIRM, Encourages Zai Lab Limited Investors to Inquire About Securities Class Action Investigation - ZLABPRNewsWire • 06/30/23
China's NMPA approves Argenx's and Zai Lab's BLA for muscle-weakening disease treatmentReuters • 06/30/23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in ChinaGlobeNewsWire • 06/30/23
Zai Lab Announces NDA Acceptance of Repotrectinib for Patients with ROS1-positive NSCLC by China's NMPAGlobeNewsWire • 06/28/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/26/23
ZLAB ALERT: The Law Offices of Vincent Wong Investigate Zai Lab Limited for Potential Violations of Securities LawsPRNewsWire • 06/26/23
ZLAB FRAUD ALERT: Jakubowitz Law is Investigating Zai Lab Limited in Connection with Potential Violations of Federal Securities LawsPRNewsWire • 06/23/23
ZLAB INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab LimitedPRNewsWire • 06/22/23
ZAI LAB ALERT: Bragar Eagel & Squire, P.C. is Investigating Zai Lab Limited on Behalf of Zai Lab Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 06/22/23
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/21/23
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Zai Lab Limited of an Investigation and Potential Class Action Lawsuit - (NASDAQ: ZLAB)PRNewsWire • 06/21/23
ZLAB NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab LimitedPRNewsWire • 06/20/23
ROSEN, A LEADING LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLABPRNewsWire • 06/17/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses In Excess of $100,000 to Contact the FirmAccesswire • 06/15/23
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/14/23
ZLAB INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLABPRNewsWire • 06/13/23
